CLINICAL_TRIALS
trial_result
· 2022-05-03
Clinical Trial Update: Nebulized Sub-dissociative Dose Ketamine for Treating Pain [Phase 4]
Summary
A Phase 4 clinical trial evaluating nebulized sub-dissociative dose ketamine for pain shows completed status with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Antonios Likourezos | Conditions: Pain | Phase 4 | Status: COMPLETED | Results posted: 2022-05-03